Efficiency Advantage Position Vero Diagnostics’ half-time testing and automated, low-volume sample processing as a business case for speed-to-report and reduced redelivery risk, targeting clinics and hospital settings that require rapid decision support and high-throughput workflows.

Polypharmacy Opportunity Leverage the Bennett Polypharmacy Profile (BPP) capability to offer providers an objective med list with streamlined reconciliation, highlighting potential collaborations with pharmacy benefit managers, care coordinators, and value-based care programs.

Integrated Automation Emphasize the combined laboratory information management system and real-time specimen tracking to reduce administrative burden for care teams, enabling targeted pilots with health systems seeking end-to-end visibility and improved data integrity.

Regulatory Readiness Highlight CLIA registration and CMS-aligned quality standards to reassure buyers in highly regulated markets; identify states with growing demand for accredited labs and tailor expansion or subcontracting partnerships accordingly.

Growth Readiness Frame Vero Diagnostics as a scalable partner for mid-market hospitals and regional labs by showcasing current revenue growth potential, room to increase volume with existing services (drug monitoring, PGx, pathogen detection, urine and blood testing), and capability to expand into additional regulated regions.